GT Biopharma
GTBP
GTBP
17 hedge funds and large institutions have $349K invested in GT Biopharma in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 9 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
17
Holders Change
-15
Holders Change %
-46.88%
% of All Funds
0.25%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
9
Closed
17
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
$10.2K |
| 2 |
UBS Group
Zurich,
Switzerland
|
$4.53K |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
$271 |
| 4 |
BNP Paribas Financial Markets
Paris,
France
|
$27 |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
26
Northern Trust
Chicago,
Illinois
| – | -$8.25K | -1,078 | Closed |
|
27
Goldman Sachs
New York
| – | -$5.83K | -762 | Closed |
|
|
MAWA
28
Moss Adams Wealth Advisors
Seattle,
Washington
| – | -$5.1K | -667 | Closed |
|
29
Jane Street
New York
| – | -$4.95K | -647 | Closed |
|
30
Commonwealth Equity Services
Waltham,
Massachusetts
| – | -$3K | -337 | Closed |
|
|
WG
31
Welch Group
Birmingham,
Alabama
| – | -$2.55K | -333 | Closed |
|
|
ASN
32
Advisory Services Network
Atlanta,
Georgia
| – | -$38 | -5 | Closed |
|
33
Qube Research & Technologies (QRT)
London,
United Kingdom
| – | -$1 | – | – |
|